Zenotech Laboratories Limited (BOM:532039)
45.08
-1.37 (-2.95%)
At close: May 14, 2026
Zenotech Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 304.24 | 267.02 | 196.86 | 111.42 | 24.15 |
Short-Term Investments | - | 0.02 | 0.02 | - | - |
Cash & Short-Term Investments | 304.24 | 267.04 | 196.88 | 111.42 | 24.15 |
Cash Growth | 13.93% | 35.64% | 76.69% | 361.42% | -1.75% |
Accounts Receivable | 87.77 | 74.54 | 32.49 | 33.24 | 39.28 |
Other Receivables | - | 11.05 | 15.33 | 6.76 | 1.58 |
Receivables | 87.77 | 85.6 | 47.82 | 39.99 | 40.86 |
Inventory | - | 0.91 | 8.6 | 0.24 | 1.35 |
Prepaid Expenses | - | 2.04 | 1.39 | 2.98 | 3.84 |
Other Current Assets | 18.38 | 4.3 | 6.94 | 8.01 | 3.56 |
Total Current Assets | 410.39 | 359.89 | 261.63 | 162.65 | 73.75 |
Property, Plant & Equipment | 658.93 | 644.41 | 675.38 | 703.64 | 711.88 |
Long-Term Deferred Tax Assets | - | 39.4 | 65.26 | 93.58 | 122.75 |
Other Long-Term Assets | 42.21 | 66.6 | 59.8 | 48.87 | 32.46 |
Total Assets | 1,112 | 1,110 | 1,062 | 1,009 | 940.84 |
Accounts Payable | 36.96 | 25.24 | 32.92 | 34.77 | 20.66 |
Accrued Expenses | 44.8 | 83.32 | 97.15 | 126.19 | 129.98 |
Current Income Taxes Payable | - | 12.15 | - | - | - |
Current Unearned Revenue | - | 5.11 | 5.11 | 5.11 | 5.11 |
Other Current Liabilities | 38.8 | 0.05 | 0.05 | - | - |
Total Current Liabilities | 120.56 | 125.87 | 135.23 | 166.07 | 155.76 |
Long-Term Debt | - | - | - | - | 60 |
Long-Term Unearned Revenue | 9.91 | 9.74 | 9.7 | 9.73 | 3.21 |
Pension & Post-Retirement Benefits | - | 7.09 | 6.16 | 5.26 | 4.52 |
Long-Term Deferred Tax Liabilities | 8.31 | - | - | - | - |
Other Long-Term Liabilities | 21.53 | 6.3 | 5.55 | 4.97 | 10.95 |
Total Liabilities | 160.32 | 149 | 156.65 | 186.03 | 234.44 |
Common Stock | 610.31 | 610.31 | 610.31 | 610.31 | 610.31 |
Additional Paid-In Capital | - | 2,095 | 2,095 | 2,095 | 2,095 |
Retained Earnings | - | -1,744 | -1,800 | -1,883 | -1,999 |
Comprehensive Income & Other | 340.91 | - | - | - | - |
Shareholders' Equity | 951.21 | 961.31 | 905.42 | 822.7 | 706.4 |
Total Liabilities & Equity | 1,112 | 1,110 | 1,062 | 1,009 | 940.84 |
Total Debt | - | - | - | - | 60 |
Net Cash (Debt) | 304.24 | 267.04 | 196.88 | 111.42 | -35.85 |
Net Cash Growth | 13.93% | 35.64% | 76.69% | - | - |
Net Cash Per Share | 5.11 | 4.38 | 3.23 | 1.83 | -0.59 |
Filing Date Shares Outstanding | 60.59 | 61.03 | 61.03 | 61.03 | 61.03 |
Total Common Shares Outstanding | 60.59 | 61.03 | 61.03 | 61.03 | 61.03 |
Working Capital | 289.83 | 234.02 | 126.4 | -3.42 | -82.01 |
Book Value Per Share | 15.70 | 15.75 | 14.84 | 13.48 | 11.57 |
Tangible Book Value | 951.21 | 961.31 | 905.42 | 822.7 | 706.4 |
Tangible Book Value Per Share | 15.70 | 15.75 | 14.84 | 13.48 | 11.57 |
Land | - | 10.83 | 10.83 | 10.83 | 10.83 |
Buildings | - | 212.53 | 211.96 | 211.96 | 211.96 |
Machinery | - | 939.58 | 917.68 | 844.97 | 828.49 |
Construction In Progress | - | 35.73 | 19.56 | 49.79 | 2.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.